RxDoctor Payments Data

Brack Hattler

Cardiovascular Disease · Aurora, CONPI 1376511923

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $818 of the $1,166 with a category attached, or 70.1%. Amgen accounts for 94.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,097 and has fallen 97.9% since, to $23 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CO, where the typical reported total is $1,537.

$1,166in general payments, 2019–2025

Across 13 payments — averaging $89.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Abbott$46
  • Boston Scientific$23
$788,762in research payments, 2019–2025

Across 204 payments — averaging $3866.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$204K
  • Abbott$110K
  • Bayer$103K
  • Amgen$89K
  • Novartis$83K
  • AstraZeneca$51K
  • plus $149K from 4 others

What the payments were for

  • Travel & lodging$81870%
  • Food & beverage$34830%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen10$1,097
Abbott2$46
Boston Scientific1$23

How this compares

$1,166 in reported general payments places this provider in the 45th percentile of 276 cardiovascular disease providers in Colorado.

See all cardiovascular disease providers in Colorado

Other cardiovascular disease in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →